| Demographic and practice characteristics | |
| Female gender | 157 (72.4) |
| Specialty | |
| Family physician | 132 (60.8) |
| Obstetrician-gynecologist | 85 (39.2) |
| Practice setting | |
| Academic | 43 (19.8) |
| Private practice | 122 (56.2) |
| Public health | 47 (21.7) |
| Trains residents or fellows | 141 (65.0) |
| ≥10 years since residency | 134 (61.8) |
| ≥10 LNG-IUSs inserted/year | 96 (44.2) |
| Knowledge | |
| General, answered correctly | |
| LNG-IUS failure rate | 177 (81.6) |
| LNG-IUS FDA-approved duration of use | 198 (91.2) |
| Perfect score on 2 general knowledge items | 163 (75.1) |
| Complications, answered correctly | |
| Infertility after removal | 206 (94.9) |
| Increased risk for PID ≥20 days after insertion | 198 (91.2) |
| Increased risk for PID <20 days after insertion | 125 (57.6) |
| Increased risk of STI | 195 (89.9) |
| Increased risk of ectopic pregnancy | 123 (56.7) |
| Complications score, mean number answered correctly out of 5 (SD)* | 3.9 (0.93) |
| Attitudes | |
| Factors that negatively influence decision to recommend LNG-IUS, answered yes | |
| Increased risk of PID/STIs/infertility | 48 (22.1) |
| Cramping/pain side effect | 25 (11.5) |
| Irregular bleeding side effect | 69 (31.8) |
| Medical liability | 4 (1.8) |
| Cost | 47 (21.7) |
| Practice | |
| Routinely recommend LNG-IUS for the following patients, answered yes | |
| Nulliparous women | 121 (55.8) |
| Women with a history of STIs/PID | 82 (37.8) |
| Women with a history of ectopic pregnancy | 81 (37.3) |
| Women <20 years old | 80 (36.9) |
Data are n (%).
↵* Complications score is calculated from number of correct answers on the 5 questions listed.
PID, pelvic inflammatory disease; SD, standard deviation; STI, sexually transmitted infection; FDA, US Food and Drug Administration.